Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.
D000284:Administration, Oral; D000818:Animals; D002439:Cefotaxime / Q000633:toxicity; D002511:Cephalosporins / Q000138:chemical synthesis* / Q000494:pharmacology; D002513:Cephamycins / Q000633:toxicity; D007202:Indicators and Reagents; D007275:Injections, Intravenous; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008826:Microbial Sensitivity Tests; D009070:Moxalactam; D013329:Structure-Activity Relationship
D002511:Cephalosporins; D002513:Cephamycins; D007202:Indicators and Reagents; D002439:Cefotaxime; D009070:Moxalactam